PHILADELPHIA – Today, United States Attorney David Metcalf announced criminal charges against three defendants in connection with an alleged pill mill conspiracy. The charges filed in federal court are part of the Department of Justice’s 2026 National Health Care Fraud Takedown.Dr. Joseph P. DiRenzo Jr., 64, of Egg Harbor Township, New Jersey, Dr. Marc A. Matozzo, 56, of Woodbury, New Jersey, and Joseph D. Norris, P.A., 62, of Philadelphia, Pennsylvania, were charged by indictment with conspiracy to unlawfully distribute controlled substances. DiRenzo and Matozzo were also each charged with two counts of unlawful distribution of controlled substances. Norris was also charged with two counts of unlawful distribution of controlled substances and one count of false statements related to health care matters. “Medical professionals who prescribe powerful drugs indiscriminately are fueling the opioid crisis that continues to grip our area,” said U.S. Attorney Metcalf. “Just like street dealers, they are perpetuating people’s pain and addiction. My office and our partners will never stop working to put pill mills out of business. We would ask anyone with knowledge of such prescription abuse to share their information with law enforcement. Doing so could save lives.”As alleged in the indictment, from January 2020 through March 2025, the defendants operated a voicemail refill line that allowed patients to request and receive refills of Schedule II controlled substance prescriptions, namely oxycodone and amphetamine, without ever interacting with a licensed and registered prescriber. The defendants prescribed to patients who used the refill line to receive prescriptions for controlled substances for up to and, in some instances, exceeding one year without interacting with a licensed prescriber. The defendants knew that certain pharmacies refused to fill certain of their controlled substances prescriptions, but defendants submitted the refused prescriptions to other pharmacies and submitted prescriptions in the name of another medical professional in order to deceive the pharmacies into filling the prescriptions. The indictment further alleges that the defendants received notice from pharmacy benefit managers and insurers that the defendants had prescribed dangerous amounts of Schedule II controlled substances and dangerous combinations of controlled substances and other medications, but they continued to prescribe these medicines. Some patients who used the refill line to obtain Schedule II controlled substances from defendants suffered drug overdoses and died. Although the defendants learned of the overdoses and deaths, they allegedly continued to operate the refill line to prescribe Schedule II controlled substances without interacting with patients. “Medical professionals occupy a position of trust and are sworn to care for and protect their patients,” said Wayne A. Jacobs, Special Agent in Charge of FBI Philadelphia. “The defendants in this case allegedly violated that trust and their professional oaths by continuing to prescribe dangerous quantities of Schedule II narcotics, even after being warned about the risks posed by their prescribing practices. At a time when our nation continues to confront an opioid crisis, conduct like this undermines public confidence in the medical profession and the tireless efforts of those working to save lives. The FBI, alongside our partners, will continue to aggressively pursue individuals who exploit positions of trust and benefit from illegal, dangerous, and, too often, fatal schemes.”“Medical providers are responsible for ensuring that controlled substances are prescribed properly,” said Maureen Dixon, Special Agent in Charge of the Philadelphia Regional Office for the U.S. Department of Health and Human Services, Office of Inspector General (HHS-OIG). “Protecting the public from dangerous provider behaviors and drug overdoses is a top priority for HHS-OIG…
Source: U.S. Department of Justice